跳至主要内容
临床试验/ISRCTN17833622
ISRCTN17833622已完成未知

AML 12 - Acute myeloid leukaemia Adults (modified)

Medical Research Council (MRC) (UK)0 个研究点目标入组 0 人开始时间: 2000年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Acute myeloid leukaemia (AML) (any type of de novo or secondary AML, including acute promyelocytic leukemia [APL])
  • 2. Suitable for intensive therapy
  • 3. Normally under the age of 60 years (but older patients can be entered if considered suitable)
  • 4. Informed consent given

排除标准

  • 1. Previous cytotoxic therapy for leukaemia
  • 2. Concurrent active malignancy
  • 3. Blast transformation of CML
  • 4. Pregnant or lactating
  • 5. Intensive chemotherapy not considered to be an appropriate treatment option
  • 6. Patients with APL are not eligible for the ATRA randomisation

研究者

发起方
Medical Research Council (MRC) (UK)

相似试验

AML 12 - Acute myeloid leukaemia Adults (modified) | 临床试验